Pharmaceutical Benchmarking Forum
Formed in 1997, the Pharmaceutical Benchmarking Forum (PBF) consists of many of the world’s leading pharmaceutical companies and has emerged as the Industry’s premier source on R&D performance metrics. Its focus is to employ careful analysis of R&D data to compare performance, examine Industry trends, answer critical business questions, and identify best practices.
As the group’s facilitator, KMR Group works with the Forum to establish rigorous processes and instructions for the definition and collection of data and to assess and present the data in a blinded and meaningful way.
The scope of the Forum extends across the full R&D spectrum, from a detailed examination of Discovery to an annual review of R&D performance, including productivity, success rates, cycle time, pipeline, and investment. In addition to its flagship study on R&D performance, the PBF sponsors focused studies on topics of interest to the Industry, ranging from the evaluation of project cost to an in-depth look at biologics R&D.
Enrollment Metrix Forum
The Enrollment Metrix Forum consists of over a dozen pharmaceutical companies which are interested in the use of enrollment metrics and improving the application of metrics in their day-to-day enrollment operations. Among its recent analyses has been a comparative assessment of key enrollment metrics and how these metrics are used at each company, as well as an assessment of Emerging Markets Trends and Experience.